Roles of Klotho and Endothelin-1 in pseudoexfoliation January 18, 2017By Laird HarrisonSerum and aqueous levels of Klotho levels are reduced in pseudoexfoliation syndrome (PXF) and pseudoexfoliative glaucoma (PEG) while Endothelin-1 (ET-1) is increased, researchers say. How glucosamine supplements may increase IOP January 04, 2017By Laird HarrisonThe finding raises questions about whether the supplements could play a role in glaucoma, wrote H. Esfandiari of the University of Medical Sciences in Tehran, Iran and colleagues in the journal Eye. Tracking treatment adherence in newly diagnosed open-angle glaucoma January 01, 2017By Lynda ChartersAn analysis of U.S. claims data reveals a substantial proportion of patients (17%) remained untreated 4 years after their initial diagnosis of open-angle glaucoma. Poor oral health may be associated with POAG January 01, 2017By Nancy GrovesRecent tooth loss and periodontal disease have been linked to primary open-angle glaucoma in a large prospective study of male health professionals. Add-on module enhances diagnostic accuracy in glaucoma January 01, 2017By Nancy GrovesA new add-on glaucoma module has the capability of creating an anatomic map of each patient’s eye by using two fixed landmarks. The module also includes an extensive reference data base. Cyclophotocoagulation device can help lower IOP January 01, 2017By Vanessa CaceresConsider factors such as glaucoma severity, eye pigmentation, and medication use when selecting power settings for the MicroPulse P3 device. Novel ocular hypotensive drug meets endpointsNetarsudil ophthalmic solution 0.02% met its primary and secondary efficacy endpoints in a third phase III trial investigating its non-inferiority to timolol maleate 0.05% for IOP lowering. Laser system offers multiple treatments in single device January 01, 2017By Laird HarrisonNew laser technology in a single device offers multiple treatment platforms, including SLT for glaucoma, laser vitreolysis for floaters, capsulotomy, and iridotomy. Exploring risk, reward in trabecular bypass, suprachoroidal devices January 01, 2017By John Berdahl MDThough much focus for stents has been in the trabecular meshwork, many companies are currently developing suprachorodial devices, which are in various stages of FDA review.